TCI GENE Inc. (TPEX:6879)
Taiwan · Delayed Price · Currency is TWD 35.10
-0.90 (-2.50%)
Mar 24, 2026, 1:41 PM CST
TCI GENE Market Cap
TCI GENE has a market cap or net worth of 932.66 million as of March 24, 2026. Its market cap has decreased by -34.84% in one year.
Market Cap
932.66M
Enterprise Value
129.40M
Revenue
273.61M
Ranking
n/a
PE Ratio
23.19
Stock Price
35.10
Market Cap Chart
Since January 25, 2022, TCI GENE's market cap has decreased from 2.14B to 932.66M, a decrease of -56.32%. That is a compound annual growth rate of -18.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 932.66M | -0.70% |
| Dec 31, 2025 | 939.28M | -34.50% |
| Dec 26, 2024 | 1.43B | -35.55% |
| Dec 29, 2023 | 2.23B | -28.42% |
| Dec 30, 2022 | 3.11B | 45.61% |
| Jan 25, 2022 | 2.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Meribank Biotech | 1.26B |
| Enimmune | 1.24B |
| Lukas Biomedical | 1.11B |
| GeneReach Biotechnology | 1.09B |
| Level Biotechnology | 1.08B |
| Holy Stone Healthcare | 1.03B |
| Taiwan Advance Bio-Pharmaceutical | 936.00M |
| NatureWise Biotech & Medicals | 916.55M |